Skip to main content
Account
Fig. 3 | Rheumatology International

Fig. 3

From: Cardiovascular safety of using non-steroidal anti-inflammatory drugs for gout: a Danish nationwide case-crossover study

Fig. 3

Non-steroidal anti-inflammatory drugs (NSAIDs) and adverse cardiovascular events in patients with gout. Number of disconcordant pairs: 13,564 for any NSAID, 7,658 for ibuprofen, 988 for naproxen, 3,152 for diclofenac. Adverse cardiovascular event is a composite of myocardial infarction, ischemic stroke, congestive heart failure, atrial fibrillation or flutter, and cardiovascular death

Back to article page